Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
29.8M
-
Shares change
-
+491K
-
Total reported value, excl. options
-
$747M
-
Value change
-
+$16M
-
Put/Call ratio
-
0.89
-
Number of buys
-
58
-
Number of sells
-
-55
-
Price
-
$25.06
Significant Holders of ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) as of Q2 2024
160 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, par value $0.001 per share as of Q2 2024.
ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.8M shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (7.52M shares), FMR LLC (2.87M shares), Frazier Life Sciences Management, L.P. (2.17M shares), BlackRock Inc. (1.77M shares), VANGUARD GROUP INC (1.42M shares), TANG CAPITAL MANAGEMENT LLC (1.33M shares), Boxer Capital, LLC (1.3M shares), STATE STREET CORP (967K shares), Palo Alto Investors LP (804K shares), and First Light Asset Management, LLC (779K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.